ICAM1 and acute lymphoblastic leukemia: Pharmacologic blockade of either the integrin lymphocyte function-associated antigen-1 (LFA-1) or its ligand ICAM-1 significantly diminished survival of human T-ALL cell lines co-cultured with BM stromal cells109.